Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer
The prognosis of epithelial ovarian cancer (EOC), the primary cause of death from gynaecological malignancies, has only modestly improved over the last decades. Immunotherapeutic treatment using a cocktail of antigens has been proposed as a “universal” vaccine strategy. We determined the expression...
Main Authors: | Renee Vermeij, Toos Daemen, Geertruida H. de Bock, Pauline de Graeff, Ninke Leffers, Annechien Lambeck, Klaske A. ten Hoor, Harry Hollema, Ate G. J. van der Zee, Hans W. Nijman |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2010-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2010/891505 |
Similar Items
-
Immunologic aspect of ovarian cancer and p53 as tumor antigen
by: van der Burg SH, et al.
Published: (2005-09-01) -
From Tumor Immunosuppression to Eradication: Targeting Homing and Activity of Immune Effector Cells to Tumors
by: Oana Draghiciu, et al.
Published: (2011-01-01) -
CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer
by: Fenne L. Komdeur, et al.
Published: (2017-09-01) -
Epitope Prediction Assays Combined with Validation Assays Strongly Narrows down Putative Cytotoxic T Lymphocyte Epitopes
by: Peng Peng Ip, et al.
Published: (2015-03-01) -
Immunological and Clinical Effects of Vaccines Targeting p53-Overexpressing Malignancies
by: R. Vermeij, et al.
Published: (2011-01-01)